Breaking News Instant updates and real-time market news.

DEO

Diageo

$116.64

0.43 (0.37%)

, WPPGY

WPP

$103.87

0.04 (0.04%)

04:55
03/22/17
03/22
04:55
03/22/17
04:55

Consumer Analyst Group of Europe to hold a conference

2017 CAGE Conference is being held in London, England on March 20-22.

DEO

Diageo

$116.64

0.43 (0.37%)

WPPGY

WPP

$103.87

0.04 (0.04%)

COT

Cott Corp.

$12.13

-0.03 (-0.25%)

GVDNY

Givaudan

$37.08

0.01 (0.03%)

NSRGY

Nestle

$77.39

-0.14 (-0.18%)

INGR

Ingredion

$120.92

0.74 (0.62%)

IFF

International Flavors

$135.10

-0.3 (-0.22%)

HRL

Hormel Foods

$34.48

-0.47 (-1.34%)

TSN

Tyson Foods

$62.26

-0.1 (-0.16%)

DANOY

Danone

$13.84

0.035 (0.25%)

SYY

Sysco

$51.80

-0.32 (-0.61%)

CCE

Coca-Cola European Partners

$36.38

0.37 (1.03%)

HEINY

Heineken

$42.99

0.3 (0.70%)

ADRNY

Ahold Delhaize

$21.61

-0.095 (-0.44%)

  • 22

    Mar

  • 25

    May

  • 20

    Jun

DEO Diageo
$116.64

0.43 (0.37%)

12/13/16
JPMS
12/13/16
NO CHANGE
JPMS
Overweight
Diageo added to European Analyst Focus List at JPMorgan
JPMorgan analyst Komal Dhillon overnight added Diageo to his firm's European Analyst Focus List. The analyst expects the shares to outperform the European Beverages sector given the company's high exposure to the U.S. and potential for material improvement in Scotch. He kept an Overweight rating on Diageo with a 2,500p price target.
07/08/16
LEHM
07/08/16
DOWNGRADE
LEHM
Equal Weight
Diageo downgraded to Equal Weight from Overweight at Barclays
10/06/16
LYON
10/06/16
INITIATION
Target $130
LYON
Outperform
Diageo initiated with an Outperform at CLSA
CLSA analyst Caroline Levy initiated Diageo with an Outperform and a $130 price target.
10/26/16
HSBC
10/26/16
UPGRADE
HSBC
Buy
Diageo upgraded to Buy from Hold at HSBC
HSBC analyst Anthony Bucalo upgraded Diageo to Buy with a price target of GBP 26 citing the company's cultural change.
WPPGY WPP
$103.87

0.04 (0.04%)

11/22/16
FBCO
11/22/16
INITIATION
FBCO
Outperform
WPP PLC initiated with an Outperform at Credit Suisse
10/31/16
PIVT
10/31/16
UPGRADE
PIVT
Buy
WPP PLC upgraded to Buy from Hold at Pivotal Research
12/08/16
JEFF
12/08/16
UPGRADE
JEFF
Buy
WPP PLC upgraded to Buy from Hold at Jefferies
Jefferies analyst Tamsin Garrity upgraded WPP PLC to Buy saying the valuation is attractive following the recent pullback. The analyst has a 1,840p price target for the shares.
01/12/17
PIVT
01/12/17
DOWNGRADE
PIVT
Hold
WPP PLC downgraded to Hold from Buy at Pivotal Research
Pivotal Research analyst Brian Wieser downgraded WPP PLC and other names in the Internet/Advertising space citing a riskier political environment post the U.S. election. Valuations do not appropriately reflect that the environment for stocks and companies is riskier now than was the case several months ago, Wieser tells investors in a research note. He believes "significant factions" within the government support "mercantilism and populism," creating uncertainty as to what policies will take effect.
COT Cott Corp.
$12.13

-0.03 (-0.25%)

12/20/16
SBSH
12/20/16
NO CHANGE
Target $15
SBSH
Buy
Cott Corp. pullback a buying opportunity, says Citi
Citi analyst Wendy Nicholson said the recent pullback in Cott is a good buying opportunity and recent management meetings give her confidence in the long-term prospects for the company.
12/06/16
12/06/16
DOWNGRADE
Target $12

Hold
Cott Corp. downgraded to Hold from Buy at Stifel
As previously reported, Stifel analyst Mark Swartzberg downgraded Cott Corp. to Hold from Buy, as he sees other companies in the space offering a better combination of fundamentals and fair or discounted multiples. The analyst lowered his price target on Cott shares to $12 from $16.
12/06/16
STFL
12/06/16
DOWNGRADE
STFL
Hold
Cott Corp. downgraded to Hold from Buy at Stifel
08/04/16
STFL
08/04/16
UPGRADE
STFL
Buy
Cott Corp. upgraded to Buy from Hold at Stifel
GVDNY Givaudan
$37.08

0.01 (0.03%)

02/13/17
EVER
02/13/17
INITIATION
EVER
Buy
Givaudan initiated with a Buy at Evercore ISI
Evercore ISI analyst Laurent Favre initiated Givaudan with a Buy rating and a CHF1900 price target.
NSRGY Nestle
$77.39

-0.14 (-0.18%)

01/23/17
SBSH
01/23/17
NO CHANGE
Target $88
SBSH
Buy
Citi discusses Mead Johnson momentum, takeout speculation
Citi analyst David Driscoll says his firm's proprietary China surveys continued to suggest on-going positive momentum for Mead Johnson (MJN). Super premium Enfinitas continues to climb the internet bestsellers list while Mead is gaining shelf space, the analyst tells investors in a research note. Driscoll notes that for the third time over the past two and a half years, takeover speculation surfaced in a media report. This time a media report said that Nestle (NSRGY) is interested in Mead. Driscoll's analysis places a $110 takeout value on the company. He keeps a buy rating on Mead with an $88 price target.
02/02/17
SBSH
02/02/17
NO CHANGE
Target $83
SBSH
Buy
Citi calls $90/share price not 'all that great' for Mead Johnson
A deal price for Mead Johnson (MJN) of $90 per share "doesn't seem all that great" given that the shares were at $92 back in July of 2016 and hit $105 in February 2015, Citi analyst David Driscoll tells investors in a research note after Reckitt Benckiser (RBGLY) confirmed overnight that it is in "advanced negotiations" to buy the baby formula maker for $90 per share. The analyst believes Mead shares could be valued at $112 in a takeover. "It is quite easy to wonder if Reckitt isn't coming along at a most opportune time when Mead's EBITDA is depressed, but on a road to recovery," Driscoll writes. The analyst thinks interest from other bidders is likely with press reports as recently as two weeks ago suggesting Nestle (NSRGY) had interest in Mead while other reports suggested interest from Danone (DANOY). Driscoll even ponders if Kraft Heinz (KHC) may "come out of the shadows." In pre-market trading, Mead shares are up 24%, or $16.50, to $86
02/02/17
WBLR
02/02/17
NO CHANGE
WBLR
Wyeth Nutrition deal implies $100/share price for Mead, says William Blair
William Blair analyst Jon Andersen says Nestle's (NSRGY) acquisition of Wyeth Nutrition a few years ago, done at 20 times EBITDA, implies a Mead Johnson (MJN) takeover price closer to $100 per share. Reckitt Benckiser (RBGLY) appears to have the financial capacity to get a deal done, Andersen tells investors in a research note after both the company and Mead confirmed the deal talks. The analyst has an Outperform rating on Mead.
01/19/17
MSCO
01/19/17
NO CHANGE
MSCO
Nestle bid for Mead Johnson would have high antitrust risk, says Morgan Stanley
After an unconfirmed media report suggested that Nestle (NSRGY) has interest in buying Mead Johnson (MJN), Morgan Stanley analyst Sanath Sudarsan said he could see the theoretical scope for synergies but also sees potential antitrust risk for any proposed hypothetical combination. Nutrition remains a core growth driver at Nestle, but the need for disposals could dilute the strategic rationale for any possible deal to buy Mead Johnson, added Sudarsan.
INGR Ingredion
$120.92

0.74 (0.62%)

02/03/17
SPHN
02/03/17
DOWNGRADE
Target $125
SPHN
Equal Weight
Ingredion downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Farha Aslam downgraded Ingredion to Equal Weight from Overweight and cut her price target on the stock to $125 from $150 citing the overhang from political developments related to Mexico.
02/03/17
JEFF
02/03/17
NO CHANGE
Target $145
JEFF
Buy
Ingredion selloff a buying opportunity, says Jefferies
Jefferies analyst Akshay Jagdale views yesterday's post-earnings weakness in shares of Ingredion as a buying opportunity. The analyst expects the company's core margins to continue improving and believes the market is "significantly undervaluing" its Specialty business. He keeps a Buy rating on Ingredion with a $145 price target.
02/03/17
SBSH
02/03/17
NO CHANGE
Target $145
SBSH
Buy
Ingredion post-earnings selloff a buying opportunity, says Citi
Citi analyst David Driscoll recommends using yesterday's post-earnings selloff in shares of Ingredion as a buying opportunity. The analyst notes that management has historically been conservative with guidance. He believes North American pricing presents upside potential to 2017 estimates and keeps a Buy rating on the shares. The analyst dropped his price target for Ingredion to $145 from $155.
09/07/16
SOCG
09/07/16
INITIATION
Target $147
SOCG
Hold
Ingredion initiated with a Hold at Societe Generale
Societe Generale initiated Ingredion with a Hold and $147 price target.
IFF International Flavors
$135.10

-0.3 (-0.22%)

01/09/17
LEHM
01/09/17
DOWNGRADE
Target $103
LEHM
Underweight
International Flavors downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Lauren Lieberman downgraded International Flavors to Underweight after lowering her U.S. Non-Food Consumer Staples sector view to Neutral from Positive. The analyst lowered her price target for the shares to $103 from $133. The analyst sees a less favorable macroeconomic backdrop in 2017 and has "fairly muted expectations" for company fundamentals in the space.
02/23/17
UBSW
02/23/17
UPGRADE
Target $138
UBSW
Buy
International Flavors upgraded to Buy from Neutral at UBS
UBS analyst John Roberts upgraded International Flavors & Fragrances to Buy citing valuation following the recent underperformance of the shares. The analyst believes investor concerns around currency, a possible emerging market slowdown and possible margin pressures from rising oil, vanilla and citrus prices are overdone. Roberts raised his price target for the shares to $138 from $129.
02/16/17
CEDG
02/16/17
DOWNGRADE
CEDG
Neutral
International Flavors downgraded to Neutral from Outperform at Consumer Edge
02/13/17
EVER
02/13/17
INITIATION
Target $125
EVER
Hold
International Flavors initiated with a Hold at Evercore ISI
Evercore ISI analyst Laurent Favre initiated International Flavors with a Hold and a $125 price target.
HRL Hormel Foods
$34.48

-0.47 (-1.34%)

02/24/17
BMOC
02/24/17
NO CHANGE
BMOC
Hormel Foods weakness creates buying opportunity, says BMO Capital
After Hormel reported lower than expected Q1 EPS, BMO Capital analyst Kenneth Zaslow blames the miss on "weaker-than-expected turkey and to a lesser extent grocery profits." He says that the company reduced its guidance due to low turkey prices and high belly prices. However, the analyst says that the downturn in the stock was overdone and creates "a compelling opportunity" to buy one of the best food companies. He expects the company's revenue growth to accelerate and keeps a $25 price target and an Outperform rating on the shares.
02/24/17
FBCO
02/24/17
NO CHANGE
Target $41
FBCO
Outperform
Hormel Foods selloff a 'compelling entry point,' says Credit Suisse
Credit Suisse analyst Robert Moskow looks at the selloff in Hormel Foods' stock following Q1 earnings as a "compelling entry point" for investors with a 9-18 month outlook. While the analyst understands the negative reaction to management's guidance reduction for fiscal 2017, he thinks the market "overreacted" to fears that the cyclical downturn in the turkey industry indicates a broader risk to earnings growth for the company going forward. Moskow reiterates an Outperform rating and $41 price target on the shares.
01/09/17
01/09/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Accenture (ACN) initiated with an Outperform at William Blair. 2. Coca-Cola European Partners was initiated with an Overweight at Barclays, while Coca-Cola (KO) and Dr Pepper Snapple (DPS) were initiated with an Equal Weight. 3. TiGenix (TIG) was initiated with a Buy at BofA/Merrill, a Buy at Canaccord, and an Outperform at Cowen. 4. WildHorse Resource (WRD) was initiated with an Overweight at Barclays, an Overweight at Piper Jaffray, an Outperform at Wells Fargo, a Buy at BofA/Merrill, a Buy at Guggenheim, and an Outperform at BMO Capital. 5. Hormel Foods (HRL) initiated with an Overweight at Piper Jaffray. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/09/17
PIPR
01/09/17
INITIATION
Target $40
PIPR
Overweight
Hormel Foods initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Sean Naughton started Hormel Foods with an Overweight rating and $40 price target. The analyst expects the shares to outperform peers despite fears on elevated pork operating margins.
TSN Tyson Foods
$62.26

-0.1 (-0.16%)

03/16/17
ARGS
03/16/17
DOWNGRADE
ARGS
Hold
Tyson Foods downgraded on probe, earnings outlook, bird flu at Argus
As noted earlier, Argus downgraded Tyson Foods to Hold from Buy. As reasons for the downgrade, analyst John Staszak cited the SEC probe of Tyson and other poultry producers, potential decelerating earnings in coming quarters, and a recent bird flu outbreak in two states.
02/07/17
JEFF
02/07/17
NO CHANGE
Target $75
JEFF
Buy
Tyson Foods price-fixing allegations unfounded, says Jefferies
Jefferies analyst Akshay Jagdale attributes yesterday's pullback in shares of Tyson Foods to concerns about the newly disclosed SEC investigation and ongoing worries about peaking margins. The SEC investigation represents a short-term overhang but Beef and Pork margins will eventually normalize, Jagdale tells investors in a post-earnings research note. The analyst believes the chicken price-fixing allegations are unfounded. He keeps a Buy rating on Tyson's with a $75 price target. The company's "value-added earnings stream remains significantly undervalued," Jagdale writes.
03/16/17
03/16/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Biogen (BIIB) was downgraded to Equal Weight from Overweight at Morgan Stanley and Market Perform from Outperform at Leerink. 2. United Continental (UAL) downgraded to In Line from Outperform at Evercore ISI. 3. Tyson Foods (TSN) downgraded to Hold from Buy at Argus with analyst John Staszak citing the SEC probe of Tyson and other poultry producers, potential decelerating earnings in coming quarters, and a recent bird flu outbreak in two states. 4. Williams-Sonoma (WSM) downgraded to Market Perform from Outperform at William Blair with analyst Daniel Hofkin citing the company's fourth quarter results. 5. Inovio (INO) downgraded to Neutral from Overweight at Piper Jaffray with analyst Charles Duncan saying a "lack of focus and advancement for any one program" poses execution risk to the broader platform, and to shareholders. The analyst lowered his price target for the shares to $9 from $13 following the company's Q4 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/16/17
ARGS
03/16/17
DOWNGRADE
ARGS
Hold
Tyson Foods downgraded to Hold from Buy at Argus
DANOY Danone
$13.84

0.035 (0.25%)

09/09/16
DBAB
09/09/16
DOWNGRADE
DBAB
Sell
Danone downgraded to Sell from Hold at Deutsche Bank
08/10/16
DADA
08/10/16
DOWNGRADE
DADA
Neutral
WhiteWave downgraded to Neutral from Buy at DA Davidson
DA Davidson downgraded WhiteWave (WWAV) based on the company's agreement to be acquired by Danone (DANOY).
10/04/16
BERN
10/04/16
NO CHANGE
BERN
Danone deal for WhiteWave unlikely to be challenged, says Bernstein
Bernstein analyst Alexia Howard said the DoJ plan to file a "second request" in its review of Danone's (DANOY) agreement to acquire WhiteWave Foods (WWAV) might delay the closing, but she believes that the transaction is very likely to close at the announced price of $56.25. She argues that the arguments for the existence of antitrust issues are weak and that any issues that may exist are likely small and addressable.
SYY Sysco
$51.80

-0.32 (-0.61%)

02/07/17
BOFA
02/07/17
NO CHANGE
Target $60
BOFA
Buy
Sysco weakness a buying opporutnity, says BofA/Merrill
BofA/Merrill analyst Marisa Sullivan said Sysco Q2 earnings best but sales growth was below her forecast due to softness in chain restaurants. Sullivan believes Sysco's margin initiatives continue to gain traction as Q2 foodservice business margins were above Q1 despite moderating deflation. The analyst believes Sysco is well-positioned for continued share gains and views the market overreaction to results as a buying opportunity. Sullivan rates Sysco a Buy with a $60 price target.
02/07/17
JPMS
02/07/17
UPGRADE
Target $57
JPMS
Overweight
Sysco upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst John Ivankoe upgraded Sysco to Overweight saying the shares should be bought in the low $50s. The stock closed down yesterday following the earnings report despite positive news regarding the company's longer-term outlook, Ivankoe tells investors in a research note. He raised his price target for the shares to $57 from $55.
02/07/17
02/07/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Biogen (BIIB) upgraded to Buy from Neutral at Citi with analyst Robyn Karnauskas saying the Alzheimer's Phase 2 data already reported and no Phase 3 results until 2019/20, upside in the stock rests on the stability of Biogen's multiple sclerosis business and success of the Spinraza launch in spinal muscular atrophy. 2. Caterpillar (CAT) upgraded to Overweight from Equal Weight at Barclays with analyst Robert Wertheimer saying investors likely will never get a chance to buy the company's revenue with as much upside as in 2017. 3. Sysco (SYY) upgraded to Overweight from Neutral at JPMorgan with analyst John Ivankoe saying the shares should be bought in the low $50s. He raised his price target for the shares to $57 from $55. 4. Nokia (NOK) upgraded to Overweight from Equal Weight at Morgan Stanley. 5. UBS (UBS) upgraded to Neutral from Underperform at BofA/Merrill with analyst Andrew Stimpson saying negative catalysts have played out. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/07/17
02/07/17
UPGRADE
Target $59

Outperform
Sysco upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Edward Kelly upgraded Sysco to Outperform from Neutral as he sees the selloff as an opportunity to own a blue-chip company in an attractive industry, with solid underlying operating momentum, and insulation from many of the structural issues plaguing the consumer sector today. He also raised his price target on the shares to $59 from $55.
CCE Coca-Cola European Partners
$36.38

0.37 (1.03%)

01/11/17
UBSW
01/11/17
UPGRADE
Target $38
UBSW
Buy
Coca-Cola European Partners upgraded to Buy from Neutral at UBS
UBS analyst Stephen Powers upgraded Coca-Cola European Partners to Buy citing a "compelling" valuation following the recent selloff and his belief the company's top-line progress can be sustained into FY17. The analyst raised his price target for the shares to $38 from $35.
03/07/17
03/07/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Aduro Biotech (ADRO) reinitiated with a Buy at Roth Capital. 2 Foundation Building Materials (FBM) initiated with a Buy at SunTrust and Citi, an Outperform at Raymond James and RBC Capital, and an Overweight at Barclays. 3. Coca-Cola European Partners (CCE) initiated with a Buy at Argus. 4. Agrium (AGU) initiated with an Outperform at Bernstein. 5. Teleflex (TFX) initiated with a Buy at Needham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/07/17
ARGS
03/07/17
INITIATION
Target $44
ARGS
Buy
Coca-Cola European Partners initiated with a Buy at Argus
Argus analyst Stephen Biggar initiated Coca-Cola European Partners with a Buy and a $44 price target citing attractive valuation and favorable earnings outlook.
HEINY Heineken
$42.99

0.3 (0.70%)

09/13/16
JEFF
09/13/16
INITIATION
JEFF
Hold
Heineken initiated with a Hold at Jefferies
Price target EUR 80.
ADRNY Ahold Delhaize
$21.61

-0.095 (-0.44%)

09/07/16
DBAB
09/07/16
INITIATION
DBAB
Buy
Ahold Delhaize reinstated with a Buy at Deutsche Bank
Deutsche Bank analyst Niamh McSherry reinstated Ahold Delhaize with a Buy rating and EUR 25 price target.
02/06/17
FBCO
02/06/17
INITIATION
FBCO
Outperform
Ahold Delhaize initiated with an Outperform at Credit Suisse
Price target EUR 24.50.
10/04/16
EXAN
10/04/16
UPGRADE
EXAN
Outperform
Ahold Delhaize upgraded to Outperform from Neutral at Exane BNP Paribas
Exane BNP Paribas analyst Andrew Gwynn upgraded Ahold Delhaize to Outperform with a price target of EUR 23.50.
11/18/16
DBAB
11/18/16
DOWNGRADE
DBAB
Hold
Ahold Delhaize downgraded to Hold from Buy at Deutsche Bank
Price target lowered to EUR 22.50 from EUR 24.

TODAY'S FREE FLY STORIES

WAC

Walter Investment

$0.51

-0.0056 (-1.09%)

10:24
10/21/17
10/21
10:24
10/21/17
10:24
Hot Stocks
Walter Investment reaches agreement on financial restructuring »

Walter Investment has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMST

TimkenSteel

$17.57

0.19 (1.09%)

10:18
10/21/17
10/21
10:18
10/21/17
10:18
Hot Stocks
Tentative agreement between TimkenSteel, United Steelworkers voted down »

TimkenSteel employees who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

AGEN

Agenus

$4.33

-0.14 (-3.13%)

, GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

10:15
10/21/17
10/21
10:15
10/21/17
10:15
Hot Stocks
FDA approves GlaxoSmithKline shingles vaccine with Agenus QS-21 Stimulon »

Agenus (AGEN) has…

AGEN

Agenus

$4.33

-0.14 (-3.13%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 06

    Nov

MS

Morgan Stanley

$50.68

0.89 (1.79%)

10:06
10/21/17
10/21
10:06
10/21/17
10:06
Periodicals
Another 20% gain in Morgan Stanley stock likely, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

SSNLF

Samsung

10:02
10/21/17
10/21
10:02
10/21/17
10:02
Periodicals
Samsung has lots of upside driven by chips/screens, Barron's says »

Samsung stock is up 50%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 30

    Oct

DLAKY

Lufthansa

$30.28

0.2 (0.66%)

09:56
10/21/17
10/21
09:56
10/21/17
09:56
Periodicals
Lufthansa has more room to climb, Barron's says »

Amid competitor's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$59.90

0.12 (0.20%)

, DAL

Delta Air Lines

$53.27

1 (1.91%)

09:51
10/21/17
10/21
09:51
10/21/17
09:51
Periodicals
Market pounds United, sees American/Delta as possibly safe bets, Barron's says »

United Continental's…

UAL

United Continental

$59.90

0.12 (0.20%)

DAL

Delta Air Lines

$53.27

1 (1.91%)

AAL

American Airlines

$51.93

0.42 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

CZR

Caesars

$12.20

0.15 (1.24%)

09:45
10/21/17
10/21
09:45
10/21/17
09:45
Periodicals
Caesars looks ready to grow again, Barron's says »

After a disastrous 2008…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 08

    Nov

DWDP

DowDuPont

$71.18

0.29 (0.41%)

09:40
10/21/17
10/21
09:40
10/21/17
09:40
Periodicals
DowDuPont shares likely to return as much as 30% over next year, Barron's says »

If DowDuPont can cut $3B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$40.35

0.88 (2.23%)

09:29
10/21/17
10/21
09:29
10/21/17
09:29
Periodicals
Coach shares look undervalued, could rise nearly 30%, Barron's says »

Coach, which has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$96.50

1.8 (1.90%)

, MOH

Molina Healthcare

$64.40

0.76 (1.19%)

09:24
10/21/17
10/21
09:24
10/21/17
09:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CNC

Centene

$96.50

1.8 (1.90%)

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

CI

Cigna

$191.42

3.2 (1.70%)

ANTM

Anthem

$194.69

1.49 (0.77%)

AET

Aetna

$160.84

3.2 (2.03%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

WCG

WellCare

$180.52

3.28 (1.85%)

CYH

Community Health

$6.44

0.24 (3.87%)

HCA

HCA Healthcare

$81.05

1.26 (1.58%)

LPNT

LifePoint

$58.35

0.5 (0.86%)

THC

Tenet

$14.66

1.31 (9.81%)

UHS

Universal Health

$112.85

2.31 (2.09%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

MSFT

Microsoft

$78.81

0.9 (1.16%)

FB

Facebook

$174.98

0.42 (0.24%)

INTC

Intel

$40.43

0.34 (0.85%)

IBM

IBM

$162.07

1.17 (0.73%)

MAR

Marriott

$115.02

-0.18 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 29

    Nov

  • 30

    Nov

  • 18

    Mar

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

08:55
10/21/17
10/21
08:55
10/21/17
08:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

08:45
10/21/17
10/21
08:45
10/21/17
08:45
General news
Breaking General news story  »

New York Federal Reserve…

FB

Facebook

$174.98

0.42 (0.24%)

, AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

08:25
10/21/17
10/21
08:25
10/21/17
08:25
Periodicals
Regulators inquiries fuel speculation about big tech breakup, Barron's says »

Facebook (FB), Amazon…

FB

Facebook

$174.98

0.42 (0.24%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 01

    Nov

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

07:58
10/21/17
10/21
07:58
10/21/17
07:58
Hot Stocks
DBV believes FDA suggested continue moving forward with Viaskin »

DBV Technologies (DBVT)…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

04:55
10/21/17
10/21
04:55
10/21/17
04:55
General news
Breaking General news story  »

New York Federal Reserve…

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

04:55
10/21/17
10/21
04:55
10/21/17
04:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

19:15
10/20/17
10/20
19:15
10/20/17
19:15
General news
Breaking General news story  »

Federal Reserve Chair…

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

18:59
10/20/17
10/20
18:59
10/20/17
18:59
Hot Stocks
FDA cannot approve Antares Pharma's Xyosted NDA »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

18:55
10/20/17
10/20
18:55
10/20/17
18:55
Conference/Events
Federal Reserve Chairperson delivers a lecture at NEC Dinner »

Federal Reserve…

SHIP

Seanergy Marine

$1.24

0.0199 (1.63%)

17:50
10/20/17
10/20
17:50
10/20/17
17:50
Syndicate
Breaking Syndicate news story on Seanergy Marine »

Seanergy Marine files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLI

Houlihan Lokey

$41.56

0.18 (0.43%)

17:49
10/20/17
10/20
17:49
10/20/17
17:49
Syndicate
Breaking Syndicate news story on Houlihan Lokey »

Houlihan Lokey files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GEO

Geo Group

$26.20

0.2 (0.77%)

17:48
10/20/17
10/20
17:48
10/20/17
17:48
Syndicate
Breaking Syndicate news story on Geo Group »

Geo Group files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

17:37
10/20/17
10/20
17:37
10/20/17
17:37
Hot Stocks
DBV sinks following peanut allergy trial miss, Aimmune soars »

Shares of DBV…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KALV

KalVista

$11.26

1.99 (21.47%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:24
10/20/17
10/20
17:24
10/20/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: KalVista (KALV),…

KALV

KalVista

$11.26

1.99 (21.47%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.